Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 9;11(8):2039.
doi: 10.3390/microorganisms11082039.

COVID Variants, Villain and Victory: A Bioinformatics Perspective

Nityendra Shukla  1 , Neha Srivastava  2 , Rohit Gupta  1 , Prachi Srivastava  2 , Jitendra Narayan  1
Affiliations

COVID Variants, Villain and Victory: A Bioinformatics Perspective

Nityendra Shukla et al. Microorganisms. .

Abstract

The SARS-CoV-2 virus, a novel member of the Coronaviridae family, is responsible for the viral infection known as Coronavirus Disease 2019 (COVID-19). In response to the urgent and critical need for rapid detection, diagnosis, analysis, interpretation, and treatment of COVID-19, a wide variety of bioinformatics tools have been developed. Given the virulence of SARS-CoV-2, it is crucial to explore the pathophysiology of the virus. We intend to examine how bioinformatics, in conjunction with next-generation sequencing techniques, can be leveraged to improve current diagnostic tools and streamline vaccine development for emerging SARS-CoV-2 variants. We also emphasize how bioinformatics, in general, can contribute to critical areas of biomedicine, including clinical diagnostics, SARS-CoV-2 genomic surveillance and its evolution, identification of potential drug targets, and development of therapeutic strategies. Currently, state-of-the-art bioinformatics tools have helped overcome technical obstacles with respect to genomic surveillance and have assisted in rapid detection, diagnosis, and delivering precise treatment to individuals on time.

Keywords: COVID-19; SARS-CoV-2; bioinformatics; drug design; genomics; immunoinformatics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Frequency of confirmed COVID-19 cases per million across the world as of June 2023 [4].
Figure 2
Figure 2
In silico vaccine development timeline [42,43].
Figure 3
Figure 3
Stacked bar chart displaying the rising rate of published computational methods across various domains over the years.
See this image and copyright information in PMC

References

    1. Centers for Disease Control Control and Prevention SARS-CoV-2 Variant Classifications and Definitions. [(accessed on 25 March 2023)];2023 Available online: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classificatio....
    1. WHO Updated Working Definitions and Primary Actions for SARS-CoV-2 Variants. 2023. [(accessed on 14 June 2023)]. Available online: https://www.who.int/publications/m/item/updated-working-definitions-and-....
    1. World Health Organization Statement on the Update of WHO’s Working Definitions and Tracking System for SARS-CoV-2 Variants of Concern and Variants of Interest. 2023. [(accessed on 14 June 2023)]. Available online: https://www.who.int/news/item/16-03-2023-statement-on-the-update-of-who-.... - PMC - PubMed
    1. Mathieu E., Ritchie H., Rodés-Guirao L., Appel C., Gavrilov D., Giattino C., Hasell J., Macdonald B., Dattani S., Beltekian D., et al. Coronavirus Pandemic (COVID-19) 2020. [(accessed on 16 June 2023)]. Available online: https://ourworldindata.org/covid-cases/
    1. Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re’Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019. - DOI - PMC - PubMed

LinkOut - more resources